DrugDashboards

Market view

guselkumab · Liquid

1 marketed package NDCs · 1 active manufacturer

Most dispensed: 100 mg/mL · Injection · #1 syringe/carton / 1 ml in 1 syringe · 200 mg/2mL · Injection · #1 syringe/carton / 2 ml in 1 syringe

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for guselkumab, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • TremfyaAug 19, 2026
    Price up
    NADAC $7309.901 → $7318.98833 per unit (+0.12%)
  • TremfyaAug 19, 2026
    Price up
    NADAC $14710.05333 → $14745.84214 per unit (+0.24%)
  • TremfyaAug 19, 2026
    Price up
    NADAC $14609.29778 → $14610.18 per unit (+0.01%)
  • TremfyaAug 19, 2026
    Price up
    NADAC $14715.71455 → $14728.90533 per unit (+0.09%)
  • TremfyaJul 22, 2026
    Price down
    NADAC $14779.632 → $14715.71455 per unit (-0.43%)
  • TremfyaJul 22, 2026
    Price down
    NADAC $7349.6703 → $7309.901 per unit (-0.54%)
  • TremfyaJul 22, 2026
    Price up
    NADAC $14597.928 → $14609.29778 per unit (+0.08%)
  • TremfyaJul 22, 2026
    Price down
    NADAC $14740.018 → $14710.05333 per unit (-0.2%)

Same drug class

Other molecules FDA puts in Interleukin-23 Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Guselkumab in shortage right now?
No. FDA does not currently list Guselkumab in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Guselkumab?
2 companies have marketed Guselkumab in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Guselkumab cost?
The typical pharmacy pays about $14,669.54 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.